4-1BB ligand activates bystander dendritic cells to enhance immunization in trans

Journal of Immunology

Volumn 193, Issue 10, 2014, Pages 5056-5064

  Macdonald, Douglas Macdonald ^a   Hotblack, Alastair ^a   Akbar, Saniath ^a   Britton, Gary ^a   Collins, Mary K ^a,b   Rosenberg, William C ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD137 LIGAND; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VIRUS NUCLEOPROTEIN; CD137 ANTIGEN; CORE PROTEIN; INFLUENZA VACCINE; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BYSTANDER EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HEMATOPOIETIC CELL; IMMUNE RESPONSE; IMMUNIZATION; INFANT; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CELL COMMUNICATION; GENE VECTOR; GENETICS; IMMUNOLOGY; LENTIVIRINAE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; TRANSCRIPTION INITIATION;

4-1BB LIGAND; ANIMALS; ANTIGENS, CD137; ANTIGENS, VIRAL; BYSTANDER EFFECT; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; IMMUNIZATION; INFLUENZA VACCINES; LENTIVIRUS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VIRAL CORE PROTEINS;

EID: 84910140360     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301723     Document Type: Article

References (41)

1. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258
2. Wang, C., G. H. Lin, A. J. McPherson, and T. H.Watts. 2009. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 229: 192-215
3. Takahashi, C., R. S. Mittler, and A. T. Vella. 1999. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J. Immunol. 162: 5037-5040
4. +FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J. Immunol. 179: 7295-7304
5. Curran, M. A., T. L. Geiger, W. Montalvo, M. Kim, S. L. Reiner, A. Al-Shamkhani, J. C. Sun, and J. P. Allison. 2013. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J. Exp. Med. 210: 743-755
6. Taraban, V. Y., T. F. Rowley, L. O'Brien, H. T. Chan, L. E. Haswell, M. H. Green, A. L. Tutt, M. J. Glennie, and A. Al-Shamkhani. 2002. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-Tumor immune responses. Eur. J. Immunol. 32: 3617-3627
7. Tan, J. T., J. K. Whitmire, R. Ahmed, T. C. Pearson, and C. P. Larsen. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163: 4859-4868
8. Bukczynski, J., T. Wen, C. Wang, N. Christie, J. P. Routy, M. R. Boulassel, C. M. Kovacs, K. S. Macdonald, M. Ostrowski, R. P. Sekaly, et al. 2005. Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L. J. Immunol. 175: 6378-6389
9. Bukczynski, J., T. Wen, K. Ellefsen, J. Gauldie, and T. H. Watts. 2004. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuVant for human antiviral cytotoxic T cell responses. Proc. Natl. Acad. Sci. USA 101: 1291-1296
10. Lin, G. H., B. J. Sedgmen, T. J. Moraes, L. M. Snell, D. J. Topham, and T. H. Watts. 2009. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J. Immunol. 182: 934-947
11. Langstein, J., J. Michel, and H. Schwarz. 1999. CD137 induces proliferation and endomitosis in monocytes. Blood 94: 3161-3168
12. Lippert, U., K. Zachmann, D. M. Ferrari, H. Schwarz, E. Brunner, A. H. Mahbub-Ul Latif, C. Neumann, and A. Soruri. 2008. CD137 ligand reverse signaling has multiple functions in human dendritic cells during an adaptive immune response. Eur. J. Immunol. 38: 1024-1032
13. Wilcox, R. A., A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, and L. Chen. 2002. Cutting edge: Expression of functional CD137 receptor by dendritic cells. J. Immunol. 168: 4262-4267
14. Laderach, D., A. Wesa, and A. Galy. 2003. 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12. Cell. Immunol. 226: 37-44
15. Melero, I., W. W. Shuford, S. A. Newby, A. Aruffo, J. A. Ledbetter, K. E. Hellström, R. S. Mittler, and L. Chen. 1997. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat. Med. 3: 682-685
16. Miller, R. E., J. Jones, T. Le, J. Whitmore, N. Boiani, B. Gliniak, and D. H. Lynch. 2002. 4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner. J. Immunol. 169: 1792-1800
17. Melero, I., A. M. Grimaldi, J. L. Perez-Gracia, and P. A. Ascierto. 2013. Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination. Clin. Cancer Res. 19: 997-1008
18. Guinn, B. A., M. A. DeBenedette, T. H. Watts, and N. L. Berinstein. 1999. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine. J. Immunol. 162: 5003-5010
19. Harrison, J. M., E. M. Bertram, D. B. Boyle, B. E. Coupar, C. Ranasinghe, and I. A. Ramshaw. 2006. 4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine. Vaccine 24: 6867-6874
20. Ganguly, S., J. Liu, V. B. Pillai, R. S. Mittler, and R. R. Amara. 2010. AdjuVantive effects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNAvaccine: different effects on cellular and humoral immunity. Vaccine 28: 1300-1309
21. Kanagavelu, S. K., V. Snarsky, J. M. Termini, S. Gupta, S. Barzee, J. A. Wright, W. N. Khan, R. S. Kornbluth, and G. W. Stone. 2012. Soluble multi-Trimeric TNF superfamily ligand adjuVants enhance immune responses to a HIV-1 Gag DNA vaccine. Vaccine 30: 691-702
22. Moraes, T. J., G. H. Lin, T. Wen, and T. H. Watts. 2011. Incorporation of 4-1BB ligand into an adenovirus vaccine vector increases the number of functional antigen-specific CD8 T cells and enhances the duration of protection against influenza-induced respiratory disease. Vaccine 29: 6301-6312
23. Suhoski, M. M., T. N. Golovina, N. A. Aqui, V. C. Tai, A. Varela-Rohena, M. C. Milone, R. G. Carroll, J. L. Riley, and C. H. June. 2007. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. Mol. Ther. 15: 981-988
24. Di Nunzio, F., T. Félix, N. J. Arhel, S. Nisole, P. Charneau, and A. S. Beignon. 2012. HIV-derived vectors for therapy and vaccination against HIV. Vaccine 30: 2499-2509
25. Esslinger, C., P. Romero, and H. R. MacDonald. 2002. Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors. Hum. Gene Ther. 13: 1091-1100
26. Breckpot, K., D. Escors, F. Arce, L. Lopes, K. Karwacz, S. Van Lint, M. Keyaerts, and M. Collins. 2010. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J. Virol. 84: 5627-5636
27. Escors, D., L. Lopes, R. Lin, J. Hiscott, S. Akira, R. J. Davis, and M. K. Collins. 2008. Targeting dendritic cell signaling to regulate the response to immunization. Blood 111: 3050-3061
28. Rowe, H. M., L. Lopes, N. Brown, S. Efklidou, T. Smallie, S. Karrar, P. M. Kaye, and M. K. Collins. 2009. Expression of vFLIP in a lentiviral vaccine vector activates NF-kappaB, matures dendritic cells, and increases CD8+ T-cell responses. J. Virol. 83: 1555-1562
29. Arce, F., H. M. Rowe, B. Chain, L. Lopes, and M. K. Collins. 2009. Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization. Mol. Ther. 17: 1643-1650
30. Karwacz, K., S. Mukherjee, L. Apolonia, M. P. Blundell, G. Bouma, D. Escors, M. K. Collins, and A. J. Thrasher. 2009. Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J. Virol. 83: 3094-3103
31. Demaison, C., K. Parsley, G. Brouns, M. Scherr, K. Battmer, C. Kinnon, M. Grez, and A. J. Thrasher. 2002. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum. Gene Ther. 13: 803-813
32. Besnier, C., Y. Takeuchi, and G. Towers. 2002. Restriction of lentivirus in monkeys. Proc. Natl. Acad. Sci. USA 99: 11920-11925
33. Lee, S. W., Y. Park, T. So, B. S. Kwon, H. Cheroutre, R. S. Mittler, and M. Croft. 2008. Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells. Nat. Immunol. 9: 917-926
34. Inaba, K., M. Inaba, M. Deguchi, K. Hagi, R. Yasumizu, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1993. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc. Natl. Acad. Sci. USA 90: 3038-3042
35. He, Y., J. Zhang, C. Donahue, and L. D. Falo, Jr. 2006. Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24: 643-656
36. Goold, H. D., D. Escors, T. J. Conlan, R. Chakraverty, and C. L. Bennett. 2011. Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors. J. Immunol. 186: 4565-4572
37. + T-cell responses. J. Virol. 82: 86-95
38. Li, Q., A. Carr, F. Ito, S. Teitz-Tennenbaum, and A. E. Chang. 2003. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. Cancer Res. 63: 2546-2552
39. Watts, A. D., N. H. Hunt, Y. Wanigasekara, G. Bloomfield, D. Wallach, B. D. Roufogalis, and G. Chaudhri. 1999. A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'. EMBO J. 18: 2119-2126
40. Du, X., G. Zheng, H. Jin, Y. Kang, J. Wang, C. Xiao, S. Zhang, L. Zhao, A. Chen, and B. Wang. 2007. The adjuVant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J. Gene Med. 9: 136-146
41. Kwon, B. S., J. C. Hurtado, Z. H. Lee, K. B. Kwack, S. K. Seo, B. K. Choi, B. H. Koller, G. Wolisi, H. E. Broxmeyer, and D. S. Vinay. 2002. Immune responses in 4-1BB (CD137)-deficient mice. J. Immunol. 168: 5483-5490